These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26617968)

  • 21. Synthesis and Antibacterial Activity of Mefloquine-Based Analogs Against Sensitive and Resistant Mycobacterium tuberculosis Strains.
    da Silva Araújo A; Moraes AM; Lourenço MCS; Pessoa CO; da Silva ET; de Souza MVN
    Curr Top Med Chem; 2019; 19(9):683-689. PubMed ID: 30836914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis, and bioevaluation of a novel class of (E)-4-oxo-crotonamide derivatives as potent antituberculosis agents.
    Ren J; Xu J; Zhang G; Xu C; Zhao L; You X; Wang Y; Lu Y; Yu L; Wang J
    Bioorg Med Chem Lett; 2019 Feb; 29(4):539-543. PubMed ID: 30630715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of gallic acid formazans as novel enoyl acyl carrier protein reductase inhibitors for the treatment of tuberculosis.
    Saharan VD; Mahajan SS
    Bioorg Med Chem Lett; 2017 Feb; 27(4):808-815. PubMed ID: 28117201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 6-Substituted 2,4-diaminopyrido[3,2-d]pyrimidine analogues of piritrexim as inhibitors of dihydrofolate reductase from rat liver, Pneumocystis carinii, and Toxoplasma gondii and as antitumor agents.
    Gangjee A; Zhu Y; Queener SF
    J Med Chem; 1998 Nov; 41(23):4533-41. PubMed ID: 9804692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel Benzylidenehydrazide-1,2,3-Triazole Conjugates as Antitubercular Agents: Synthesis and Molecular Docking.
    Shaikh MH; Subhedar DD; Nawale L; Sarkar D; Khan FAK; Sangshetti JN; Shingate BB
    Mini Rev Med Chem; 2019; 19(14):1178-1194. PubMed ID: 30019644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expansion of a novel lead targeting M. tuberculosis DHFR as antitubercular agents.
    Sharma K; Tanwar O; Deora GS; Ali S; Alam MM; Zaman MS; Krishna VS; Sriram D; Akhter M
    Bioorg Med Chem; 2019 Apr; 27(7):1421-1429. PubMed ID: 30827867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3,5-disubstituted pyridines with potent activity against drug-resistant
    Sangu KG; Azger Dusthackeer VN; Singh VK; Maykalwar S; Krishna EV; Angayarkanni B; Maitra R; Chopra S; Misra S; Rode HB
    Future Med Chem; 2024 Oct; ():1-19. PubMed ID: 39363626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preliminary in vitro studies on two potent, water-soluble trimethoprim analogues with exceptional species selectivity against dihydrofolate reductase from Pneumocystis carinii and Mycobacterium avium.
    Forsch RA; Queener SF; Rosowsky A
    Bioorg Med Chem Lett; 2004 Apr; 14(7):1811-5. PubMed ID: 15026078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ligand binding studies, preliminary structure-activity relationship and detailed mechanistic characterization of 1-phenyl-6,6-dimethyl-1,3,5-triazine-2,4-diamine derivatives as inhibitors of Escherichia coli dihydrofolate reductase.
    Srinivasan B; Tonddast-Navaei S; Skolnick J
    Eur J Med Chem; 2015 Oct; 103():600-14. PubMed ID: 26414808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical and microbiological evaluation of
    Vartak A; Goins C; de Moura VCN; Schreidah CM; Landgraf AD; Lin B; Du J; Jackson M; Ronning DR; Sucheck SJ
    Medchemcomm; 2019 Jul; 10(7):1197-1204. PubMed ID: 31741730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, Synthesis, and Biological Evaluation of Pyrazolo[1,5-a]pyridine-3-carboxamides as Novel Antitubercular Agents.
    Tang J; Wang B; Wu T; Wan J; Tu Z; Njire M; Wan B; Franzblauc SG; Zhang T; Lu X; Ding K
    ACS Med Chem Lett; 2015 Jul; 6(7):814-8. PubMed ID: 26191372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis, and In vitro antituberculosis activity of 2(5H)-Furanone derivatives.
    Ngwane AH; Panayides JL; Chouteau F; Macingwana L; Viljoen A; Baker B; Madikane E; de Kock C; Wiesner L; Chibale K; Parkinson CJ; Mmutlane EM; van Helden P; Wiid I
    IUBMB Life; 2016 Aug; 68(8):612-20. PubMed ID: 27346745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel tetrazoloquinoline-rhodanine conjugates: Highly efficient synthesis and biological evaluation.
    Subhedar DD; Shaikh MH; Nawale L; Yeware A; Sarkar D; Khan FA; Sangshetti JN; Shingate BB
    Bioorg Med Chem Lett; 2016 May; 26(9):2278-83. PubMed ID: 27013391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2,4-Diaminopyrido[3,2-d]pyrimidine inhibitors of dihydrofolate reductase from Pneumocystis carinii and Toxoplasma gondii.
    Rosowsky A; Forsch RA; Queener SF
    J Med Chem; 1995 Jul; 38(14):2615-20. PubMed ID: 7629801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of 5-methyl-5-deaza nonclassical antifolates as inhibitors of dihydrofolate reductases and as potential antipneumocystis, antitoxoplasma, and antitumor agents.
    Gangjee A; Shi J; Queener SF; Barrows LR; Kisliuk RL
    J Med Chem; 1993 Oct; 36(22):3437-43. PubMed ID: 8230134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Pyrazolo[1,5-
    Hu X; Wan B; Liu Y; Shen J; Franzblau SG; Zhang T; Ding K; Lu X
    ACS Med Chem Lett; 2019 Mar; 10(3):295-299. PubMed ID: 30891129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and antiparasitic and antitumor activity of 2, 4-diamino-6-(arylmethyl)-5,6,7,8-tetrahydroquinazoline analogues of piritrexim.
    Rosowsky A; Papoulis AT; Forsch RA; Queener SF
    J Med Chem; 1999 Mar; 42(6):1007-17. PubMed ID: 10090784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of 1,2,4-Triazole-5-Thione Derivatives as Potential Inhibitors of Enoyl Acyl Carrier Protein Reductase (InhA) in Tuberculosis.
    Vora D; Upadhyay N; Tilekar K; Jain V; Ramaa CS
    Iran J Pharm Res; 2019; 18(4):1742-1758. PubMed ID: 32184843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative structure-activity relationship of triazine-antifolate inhibition of Leishmania dihydrofolate reductase and cell growth.
    Booth RG; Selassie CD; Hansch C; Santi DV
    J Med Chem; 1987 Jul; 30(7):1218-24. PubMed ID: 3599028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.